Results 111 to 120 of about 30,710 (255)

Therapeutic efficacy of lanthanum carbonate combined with meglumine cyclophosphate on patients with uremia cardiomyopathy

open access: yesLinchuang shenzangbing zazhi, 2015
Objective To study the relationship of heart rate turbulence(HRT) in patients with uremia cardiomyopathy and investigate the curative effect and security of lanthanum carbonate combined with meglumine cyclophosphate(MAC) in patients with uremia ...
CHEN Xin   +3 more
doaj  

Intima‐Media Thickness Progression Rate and Primary Unassisted Patency Failure in Arteriovenous Fistulas: A Prospective Cohort Study

open access: yesHemodialysis International, EarlyView.
ABSTRACT Background Failure of autogenous arteriovenous fistulas (AV fistulas) due to venous neointimal hyperplasia is a major clinical challenge. Whether the rate of progression in venous intima‐media thickness predicts primary unassisted patency failure remains unknown.
Gen Li, Zhengjiang Cao
wiley   +1 more source

Small Bowel Lesions and Bleeding Risk in Hemodialysis Patients: A Narrative Review

open access: yesHemodialysis International, EarlyView.
ABSTRACT Background Gastrointestinal bleeding is very common among hemodialysis patients. This high bleeding risk is caused by uremic platelet dysfunction, vascular fragility, intradialytic hemodynamic instability, and widespread antithrombotic therapy.
Andreas Smyrlis   +3 more
wiley   +1 more source

Free carnitine in diseased condition of uremia.

open access: yes, 2015
(a): A 2D Bar chart depicting relative concentrations of Long Chain carnitine and Long Chain acyl-CoA in normal and diseased conditions. (b): A 2D Bar chart depicting relative concentrations of Long Chain acyl-CoAs in normal and diseased conditions. (c):
Abhishek Sengupta (751387)   +3 more
core   +1 more source

Tenapanor Beyond Phosphate: Gut Sodium Transport, Stool Transit Time, and Volume Balance in Dialysis Patients

open access: yesHemodialysis International, EarlyView.
ABSTRACT Introduction Tenapanor, a minimally absorbed intestinal NHE3 inhibitor approved for hyperphosphatemia in dialysis, lowers phosphate and reduces intestinal sodium absorption. Its sodium–water signal may have implications beyond phosphate but remains poorly separated from diarrhea‐mediated losses and dialysis prescription artifacts. Methods This
Lucas Maciel de Almeida Corrêa   +8 more
wiley   +1 more source

CYTOGENETIC STUDIES IN PATIENTS WITH UREMIA BEFORE HEMODIALYSIS (A PRELIMINARY STUDY)

open access: yesEurasian Journal of Medicine, 2019
This study has been planned to elucidate the effect of uremia on human genome. For this purpouse, on the mitotic metaphases obtained from the cultured periferic blood samples of 18 patient with uremia to be given hemodialysis treatment for the first time
Sıtkı Öztaş   +4 more
doaj  

PREDOMÍNIO DA ALTERAÇÃO DE UREMIA EM PACIENTES NEUROPSIQUIÁTRICOS [PDF]

open access: yes
Introdução: A relação entre uremia e transtornos neuropsiquiátricos tem sido um tema de crescente interesse na literatura médica, especialmente devido aos impactos significativos que essas condições têm sobre a qualidade de vida dos pacientes.
Moret, Lívia Cavalcanti   +11 more
core   +1 more source

Mental Health Disorders in End‐Stage Kidney Disease: A Narrative Review of Clinical Considerations for Integrated Management

open access: yesHemodialysis International, EarlyView.
ABSTRACT Introduction End stage kidney disease (ESKD) is associated with a high prevalence of depression and anxiety, arising from both biological factors and the psychosocial burden of chronic dialysis care. Approximately 25%–30% of dialysis patients experience clinically significant depressive symptoms when assessed by structured clinical interview ...
Kunal Malhotra   +2 more
wiley   +1 more source

Compositional characteristics of the gut microbiome in patients with uremia

open access: yes
During acute or chronic uremia, the cumulative harmful effects of uremic toxins result in numerous health problems and, ultimately, mortality. Previous research has identified that uremic retention solutes originate from the gut microbiome, indicating ...
Peng Wang   +7 more
core   +1 more source

Montelukast Versus Gabapentin for Uremic Pruritus in Twice‐Weekly Hemodialysis Patients: A 52‐Week Prospective Non‐Randomized Open‐Label Comparative Study

open access: yesHemodialysis International, EarlyView.
ABSTRACT Background Uremic pruritus (UP) remains a common and distressing complication in patients with end‐stage renal disease (ESRD) receiving maintenance hemodialysis. The burden is particularly pronounced in low‐ and middle‐income countries where twice‐weekly hemodialysis is frequently practiced because of resource limitations. Gabapentin is widely
Bilal Mohsin   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy